Nektar Therapeutics vs Q32 Bio
NKTR and QTTB side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NKTR and QTTB compare
Nektar Therapeutics is the larger company, worth 4.8 times as much as Q32 Bio ($1.2B against $257M).
Nektar Therapeutics scores higher on the StockData Score (9 against 8 for Q32 Bio), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NKTR | QTTB |
|---|---|---|
| Size and price | ||
| Market cap | $1.2B | $257M |
| Share price | $35.91 | $8.63 |
| Change, 1 year | −36.6% | 300% |
| Change, 5 years | −78.6% | −90.8% |
| Beta (5Y) | 0.65 | −0.98 |
| Employees | 63 | 24 |
| StockData Score | ||
| Total score | 9 (better) | 8 |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 2 (better) | 1 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 22.2× | – |
| P/B | 1.4× (better) | 2.4× |
| EV/EBITDA | – | 7.0× |
| FCF yield | −17.0% | – |
| Growth | ||
| Revenue growth (TTM) | −43.9% | – |
| Revenue growth, 5Y average | −18.4% | 81.9% (better) |
| Profitability | ||
| Gross margin | 100% | – |
| Operating margin | −254% | – |
| Net margin | −297% | – |
| FCF margin | −378% | – |
| Return on equity | −37.3% | 72.1% (better) |
| Return on invested capital | −1186% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 10.42 | 20.30 (better) |
| Altman Z-score | −0.72 | 14.49 (better) |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | 0.00% (better) | −4.0% |
| Shareholder yield | 0.00% (better) | −4.0% |
| Ownership | ||
| Held by institutions | 105% | 74.6% |
| Held by insiders | 0.46% | 28.9% |
| Insider net buying, 12 months | −$2.2M | $29.5M (better) |
| Short interest, % of float | 19.9% | 26.4% |
Go deeper
- NKTR stock overview
- NKTR income statement
- NKTR valuation and score
- QTTB stock overview
- QTTB income statement
- QTTB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.